Eurofins Genomics Blue Heron Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 22

Employees

  • Latest Deal Type
  • M&A

Eurofins Genomics Blue Heron General Information

Description

Developer of a genemaker technology created to advance research in gene synthesis. The company's technology constructs oligonucleotide synthesis, sanger sequencing, next-generation sequencing and gene synthesis, assisting medical researchers in pharmaceutical and biotechnology companies with gene creation services.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 22310 20th Avenue Southeast
  • Suite 100
  • Bothell, WA 98021
  • United States
+1 (800)
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • 22310 20th Avenue Southeast
  • Suite 100
  • Bothell, WA 98021
  • United States
+1 (800)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Eurofins Genomics Blue Heron Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Merger/Acquisition 06-Aug-2019 Completed Generating Revenue
9. Merger/Acquisition 12-Aug-2010 Completed Generating Revenue
8. Later Stage VC (Series D) 19-Dec-2006 Completed Startup
7. Grant 20-Mar-2006 Completed Generating Revenue
6. Grant 16-Sep-2005 Completed Generating Revenue
5. Grant 09-Sep-2004 Completed Startup
4. Grant 01-Jan-2003 Completed Startup
3. Early Stage VC (Series B) Completed Startup
2. Early Stage VC (Series A) Completed Startup
1. Grant 01-Jan-2000 $127K Completed Startup
To view Eurofins Genomics Blue Heron’s complete valuation and funding history, request access »

Eurofins Genomics Blue Heron Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a genemaker technology created to advance research in gene synthesis. The company's technology constructs o
Biotechnology
Bothell, WA
22 As of 2026

South Plainfield, NJ
 

Coralville, IA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Eurofins Genomics Blue Heron Competitors (16)

One of Eurofins Genomics Blue Heron’s 16 competitors is Genewiz, a Formerly VC-backed company based in South Plainfield, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genewiz Formerly VC-backed South Plainfield, NJ
Integrated DNA Technologies Formerly PE-Backed Coralville, IA
Molecular Cloning Laboratories Corporation South San Francisco, CA
DNA Script Venture Capital-Backed Paris, France
ATUM (Discovery Tools) Private Equity-Backed Newark, CA
You’re viewing 5 of 16 competitors. Get the full list »

Eurofins Genomics Blue Heron Patents

Eurofins Genomics Blue Heron Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2543014-A1 Solid phase methods for polynucleotide production Inactive 15-Oct-2003
US-20050106606-A1 Enhancing hybridization of gene sequences to microarrays via alternating locomotive forces; gene expression analysis Active 01-Apr-2002
US-7482119-B2 Enhancing hybridization of gene sequences to microarrays via alternating locomotive forces; gene expression analysis Inactive 01-Apr-2002
US-20090137027-A1 Solid phase methods for polynucleotide production Inactive 01-Apr-2002
US-7164992-B1 Method and system for polynucleotide synthesis Inactive 22-Mar-2001 G16C20/10
To view Eurofins Genomics Blue Heron’s complete patent history, request access »

Eurofins Genomics Blue Heron Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Eurofins Genomics Blue Heron Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Crabtree Partners PE/Buyout Minority
Integra Ventures Venture Capital Minority
Invitrogen Corporation Minority
National Institute of General Medical Sciences Government
Origene Corporation Majority
You’re viewing 5 of 9 investors. Get the full list »

Eurofins Genomics Blue Heron FAQs

  • When was Eurofins Genomics Blue Heron founded?

    Eurofins Genomics Blue Heron was founded in 1999.

  • Where is Eurofins Genomics Blue Heron headquartered?

    Eurofins Genomics Blue Heron is headquartered in Bothell, WA.

  • What is the size of Eurofins Genomics Blue Heron?

    Eurofins Genomics Blue Heron has 22 total employees.

  • What industry is Eurofins Genomics Blue Heron in?

    Eurofins Genomics Blue Heron’s primary industry is Biotechnology.

  • Is Eurofins Genomics Blue Heron a private or public company?

    Eurofins Genomics Blue Heron is a Private company.

  • What is Eurofins Genomics Blue Heron’s current revenue?

    The current revenue for Eurofins Genomics Blue Heron is .

  • How much funding has Eurofins Genomics Blue Heron raised over time?

    Eurofins Genomics Blue Heron has raised $3.68M.

  • Who are Eurofins Genomics Blue Heron’s investors?

    Crabtree Partners, Integra Ventures, Invitrogen, National Institute of General Medical Sciences, and Origene are 5 of 9 investors who have invested in Eurofins Genomics Blue Heron.

  • Who are Eurofins Genomics Blue Heron’s competitors?

    Genewiz, Integrated DNA Technologies, Molecular Cloning Laboratories, DNA Script, and ATUM (Discovery Tools) are some of the 16 competitors of Eurofins Genomics Blue Heron.

  • When was Eurofins Genomics Blue Heron acquired?

    Eurofins Genomics Blue Heron was acquired on 06-Aug-2019.

  • Who acquired Eurofins Genomics Blue Heron?

    Eurofins Genomics Blue Heron was acquired by Eurofins Genomics Europe Shared Services.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process